Almirall to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Carlos Gallardo, Chairman of Almirall, will represent the company in a session scheduled at 9am Pacific Standard Time on January 10th, 2023 Almirall, S.A. (ALM), a global biopharmaceutical